Yufei Liu

Assistant Clinical Professor

City of Hope

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Yufei Liu is an Assistant Clinical Professor at City of Hope in the United States. His research focuses on innovative treatment strategies for non-small cell lung cancer, including the integration of ctDNA analysis and radiomics for risk assessment and the investigation of various treatment approaches such as ablative radiotherapy and immunotherapy. Liu's recent articles examine crucial factors influencing patient outcomes in advanced lung cancer, reflecting his commitment to improving therapeutic efficacy and understanding tumor dynamics.

Articles (8)

Year:

2025

Year:

2025

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

Terence Williams

City Of Hope National Medical Center

UNITED STATES

View details

David Kurtz

Assistant Professor

Stanford University

UNITED STATES

View details

Michael F. Gensheimer

Stanford University School of Medicine

UNITED STATES

View details

Mohammad Shahrokh Esfahani

Assistant Professor

Stanford University

UNITED STATES

View details

Luis Perles

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yufei Liu

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer

Treatment Approaches for Oligoprogressive Non-Small Cell Lung Cancer: A Review of Ablative Radiotherapy

Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial.

Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Consolidative Durvalumab.

Dosimetric Uncertainties Resulting From Interfractional Anatomic Variations for Patients Receiving Pancreas Stereotactic Body Radiation Therapy and Cone Beam Computed Tomography Image Guidance.

Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study.

Predicting per-lesion local recurrence in locally advanced non-small cell lung cancer following definitive radiation therapy using pre- and mid-treatment metabolic tumor volume.

Circulating Tumor DNA Dynamics Predict Benefit from Consolidation Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer.

Collaborators (5)

Terence Williams

David Kurtz

Michael F. Gensheimer

Mohammad Shahrokh Esfahani

Luis Perles

Make your next move.